ArticleFrontiers in surgery2025
Pushing the boundaries in autologous breast reconstruction: innovations from imaging to artificial intelligence.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Entirely Robotic-assisted Microsurgical Anastomoses in Autologous Breast Reconstruction.Plastic and reconstructive surgery. Global open · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains the most commonly diagnosed malignancy among women worldwide, with surgical intervention, ranging from breast-conserving procedures to total mastectomy, representing a cornerstone of curative treatment. In this context, breast reconstruction has become an essential component of comprehensive cancer treatment, addressing not only physical restoration but also playing a vital role in psychosocial rehabilitation and body image. Among the various reconstructive options, autologous tissue transfer has emerged as the preferred method for many patients, offering durable and natural-feeling results. In particular, abdominal-based free flaps such as the Deep Inferior Epigastric Perforator (DIEP) flap and the muscle-sparing Transverse Rectus Abdominis Myocutaneous (ms-TRAM) flap offer excellent results with reduced donor side morbidity. As the global number of breast cancer continues to rise, the demand for safe, individualized, and functionally superior reconstructive options rises as well. This article aims to provide a general overview of current surgical approaches and to highlight perspectives for future innovations in improving autologous breast reconstruction and patient satisfaction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.